Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Shibata

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Oncology Letters|February 14, 2018
Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanismYoshitaka Sekine, Hiroshi Nakayama, Yoshiyuki Miyazawa, et al.
International Journal of Cancer|April 27, 2018
Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screeningRyo Oki, Kazuto Ito, Rie Suzuki, et al.
BMC Cancer|March 22, 2025
The combination of poly(ADP-ribose) polymerase inhibitor and statin inhibits the proliferation of human castration-resistant and taxane-resistant prostate cancer cells in vitro and in vivoYoshitaka Sekine, Daisuke Oka, Akira Ohtsu, et al.
In Vivo (Athens, Greece)|January 6, 2021
Prognostic Factors in Hormone-sensitive Prostate Cancer Patients Treated With Combined Androgen Blockade: A Consecutive 15-year Study at a Single Japanese InstituteYoshiyuki Miyazawa, Yoshitaka Sekine, Seiji Arai, et al.
Human Genome Variation|June 13, 2020
Polo-like kinase 4 and Stromal antigen 3 are not associated with recurrent pregnancy loss caused by embryonic aneuploidyHiroyuki Yoshihara, Mayumi Sugiura-Ogasawara, Fumiko Ozawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 8, 2011
[Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study]Kiyohide Fujimoto, Yoshihiko Hirao, Yasuo Ohashi, et al.
Anticancer Research|October 30, 2016
Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate CancerHaruo Kato, Yosuke Furuya, Yoshiyuki Miyazawa, et al.
BMC Urology|October 13, 2021
Presepsin as a predictor of septic shock in patients with urinary tract infectionYoshitaka Sekine, Kazuhiko Kotani, Daisuke Oka, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 27, 2017
A CASE OF GROWING TERATOMA SYNDROMEKyoko Baba, Yoshitaka Sekine, Sota Kurihara, et al.
The Prostate|July 24, 2019
An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progressionYoshiyuki Miyazawa, Yoshitaka Sekine, Nobuaki Shimizu, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Oncology Letters|February 14, 2018
Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanismYoshitaka Sekine, Hiroshi Nakayama, Yoshiyuki Miyazawa, et al.
International Journal of Cancer|April 27, 2018
Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screeningRyo Oki, Kazuto Ito, Rie Suzuki, et al.
BMC Cancer|March 22, 2025
The combination of poly(ADP-ribose) polymerase inhibitor and statin inhibits the proliferation of human castration-resistant and taxane-resistant prostate cancer cells in vitro and in vivoYoshitaka Sekine, Daisuke Oka, Akira Ohtsu, et al.
In Vivo (Athens, Greece)|January 6, 2021
Prognostic Factors in Hormone-sensitive Prostate Cancer Patients Treated With Combined Androgen Blockade: A Consecutive 15-year Study at a Single Japanese InstituteYoshiyuki Miyazawa, Yoshitaka Sekine, Seiji Arai, et al.
Human Genome Variation|June 13, 2020
Polo-like kinase 4 and Stromal antigen 3 are not associated with recurrent pregnancy loss caused by embryonic aneuploidyHiroyuki Yoshihara, Mayumi Sugiura-Ogasawara, Fumiko Ozawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 8, 2011
[Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study]Kiyohide Fujimoto, Yoshihiko Hirao, Yasuo Ohashi, et al.
Anticancer Research|October 30, 2016
Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate CancerHaruo Kato, Yosuke Furuya, Yoshiyuki Miyazawa, et al.
BMC Urology|October 13, 2021
Presepsin as a predictor of septic shock in patients with urinary tract infectionYoshitaka Sekine, Kazuhiko Kotani, Daisuke Oka, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 27, 2017
A CASE OF GROWING TERATOMA SYNDROMEKyoko Baba, Yoshitaka Sekine, Sota Kurihara, et al.
The Prostate|July 24, 2019
An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progressionYoshiyuki Miyazawa, Yoshitaka Sekine, Nobuaki Shimizu, et al.
Pageof 9